Pharma co. RPG Life Sciences eyes another acquisition with Rs.500-Cr capital pool

Mumbai-based integrated pharmaceutical company RPG Life Sciences plans to deploy approximately INR 500 crore from its existing capital pool to acquire an additional asset within the next 12 months. The company is seeking an asset that holds US Food and Drug Administration approval or offers operational synergies. The firm recently made acquisitions of Actis Therapeutics and Raghav Lifesciences, with the backing of private equity firm InvAscent.RPG Life Sciences manages a formulation business and an active pharmaceutical ingredient (API) segment. The firm recently transferred its API business to its wholly owned subsidiary, RPG Active Pharma, to create a focused entity with dedicated capital and management. RPG Life Sciences is also focusing on scaling its international presence in regulated markets, including Europe and Canada, as well as emerging markets in Latin America and Africa.